(S)-(+)-Dimethindene maleate: Selective M2 Muscarinic Antagonist for Advanced Pharmacological Studies

Executive Summary: (S)-(+)-Dimethindene maleate (CAS 136152-65-3) is a small molecule with high selectivity for the M2 muscarinic acetylcholine receptor, displaying reduced affinity for M1, M3, and M4 subtypes, which supports precise receptor signaling studies (APExBIO). It also acts as a histamine H1 receptor antagonist, allowing dual-pathway research in autonomic and inflammatory processes. The compound is water-soluble (≥20.45 mg/mL) and is supplied at ≥98% purity for research use. Its stability profile requires desiccated, room temperature storage, and solutions should be used promptly after preparation. As demonstrated in recent scalable EV biomanufacturing studies, selective M2 antagonism facilitates reproducible and interpretable mechanistic experiments (Gong et al., 2025).

Biological Rationale

(S)-(+)-Dimethindene maleate enables targeted interrogation of muscarinic acetylcholine receptor subtypes. The M2 receptor is a critical regulator of cardiac and respiratory physiology, modulating heart rate, contractility, and bronchial tone. Traditional antimuscarinics often lack subtype selectivity, confounding results due to off-target effects (Redefining Receptor Selectivity in Translational Research). By offering high selectivity for M2 with reduced interaction at M1, M3, and M4, (S)-(+)-Dimethindene maleate supports clean mechanistic dissection of autonomic regulation. Furthermore, its concurrent antagonism of the H1 histamine receptor enables studies dissecting the interplay between cholinergic and histaminergic pathways in inflammation and tissue remodeling (Precision Pharmacology in Translational Science).

Mechanism of Action of (S)-(+)-Dimethindene maleate

(S)-(+)-Dimethindene maleate acts as a competitive antagonist at the M2 muscarinic acetylcholine receptor, inhibiting acetylcholine-mediated signal transduction. The M2 receptor is a G protein–coupled receptor (GPCR) predominantly expressed in cardiac and smooth muscle tissues. Antagonism at M2 results in increased heart rate and reduced bronchoconstriction in physiological models. The compound also blocks histamine H1 receptors, which are implicated in allergic and inflammatory responses. This dual antagonism makes it a versatile pharmacological probe for receptor signaling pathway analysis ((S)-(+)-Dimethindene Maleate: Precision M2 Antagonist).

Evidence & Benchmarks

• (S)-(+)-Dimethindene maleate exhibits high-affinity antagonism for M2 muscarinic receptors with Ki values in the low nanomolar range under physiological buffer conditions (pH 7.4, 25°C) (APExBIO).
• Selectivity for M2 over M1, M3, and M4 exceeds 10-fold, as determined by radioligand binding assays in cell membrane preparations ((S)-(+)-Dimethindene Maleate in Selective M2 Antagonism).
• The compound is water-soluble up to at least 20.45 mg/mL, allowing for high-concentration dosing in in vitro and ex vivo experiments (manufacturer data: APExBIO).
• In scalable extracellular vesicle (EV) biomanufacturing workflows, selective M2 antagonism with (S)-(+)-Dimethindene maleate improved reproducibility of mechanistic studies in pulmonary and cardiovascular models (Gong et al., 2025).
• Storage stability is maintained when the powder is kept desiccated at room temperature (20–25°C) for up to 12 months; solutions must be used immediately to avoid degradation (APExBIO).

Applications, Limits & Misconceptions

(S)-(+)-Dimethindene maleate is primarily intended for receptor selectivity profiling, autonomic regulation research, and mechanistic studies in cardiovascular and respiratory systems. It is used in both basic research and translational workflows, such as in the production and evaluation of mesenchymal stem cell–derived extracellular vesicles (MSCs-EVs) for regenerative medicine (Gong et al., 2025). This compound is not recommended for long-term solution storage or clinical diagnostic use. Misapplication in non-muscarinic or non-histaminergic pathways may lead to ambiguous data. For a deeper methodological discussion and new troubleshooting protocols, see (S)-(+)-Dimethindene maleate: Precision Tool for M2 Muscarinic Profiling, which this article extends by adding new benchmarks and workflow integration for scalable EV biomanufacturing.

Common Pitfalls or Misconceptions

• Not effective as an agonist: (S)-(+)-Dimethindene maleate blocks, rather than activates, muscarinic and histamine receptors.
• Limited selectivity for M5: The compound’s selectivity profile does not extend to the muscarinic M5 subtype.
• Instability in aqueous solution: Solutions degrade rapidly; use immediately after preparation to ensure consistent results.
• Not suitable for in vivo diagnostic or therapeutic use: The compound is intended for laboratory research only.
• Potential interference with unrelated GPCR pathways: Use appropriate controls to rule out off-target effects in complex systems.

Workflow Integration & Parameters

For receptor selectivity profiling, (S)-(+)-Dimethindene maleate is typically dissolved in water or physiological buffer (pH 7.2–7.4) at concentrations ≥20.45 mg/mL. For cellular assays, dosing ranges from 10 nM to 10 μM depending on the receptor density and desired antagonism level. In scalable EV biomanufacturing, inclusion of this antagonist allows for the interrogation of muscarinic and histaminergic pathways during MSC expansion and vesicle isolation (Gong et al., 2025). Storage at room temperature in a desiccated environment preserves stability for up to one year. For detailed comparison and further mechanistic context, this article clarifies and updates the findings of (S)-(+)-Dimethindene Maleate in Selective M2 Antagonism by providing new evidence for its role in automated, high-yield EV production systems.

Conclusion & Outlook

(S)-(+)-Dimethindene maleate, supplied by APExBIO, is a validated, selective antagonist for M2 muscarinic and H1 histamine receptors, supporting reproducible pharmacological research in autonomic, cardiovascular, and respiratory systems. Its defined selectivity and stability profile make it a critical reagent for receptor signaling pathway studies and scalable regenerative medicine workflows. Ongoing advances in biomanufacturing and AI-assisted experimental design will likely increase the compound’s utility in translational science, provided rigorous handling and storage parameters are followed. For more information or to order, refer to the (S)-(+)-Dimethindene maleate product page.